Recent Finacing
Recent Raise
TheraVasc develops an oral sustained-release sodium nitrite to improve blood flow and stimulate angiogenesis in diabetic peripheral artery disease, conducting Phase 1 and Phase 2a trials in Cleveland.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
